Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

David Strausser

Orthopaedic Surgery of the Spine The Woodlands, TX Medical Doctor

NPI 1528062866 CMS profile 250444

1441 Woodstead Ct, Ste 300, The Woodlands, TX 77380

Open in the dashboard

General payments

$15,338

33 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, David Strausser of The Woodlands, TX is reported in the CMS Open Payments database as having received $15,338 across 33 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 53rd percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $19 1
2023 General $51 1
2022 General $55 2
2021 General $107 5
2020 General $2,818 10
2019 General $12,289 14

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Strausser
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to David Strausser were reported at $0. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year David Strausser Orthopaedic Surgery of the Spine median Middle half National median
2019 $12,289 $2,106 $337–$18,608 $163
2020 $2,818 $1,213 $156–$15,082 $114
2021 $107 $1,834 $271–$15,617 $132
2022 $55 $2,015 $320–$17,036 $149
2023 $51 $1,925 $336–$14,599 $160
2024 $19 $2,110 $341–$12,483 $164
2025 $0 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Amendia, Inc. $12,251 12 payments
  2. Spinal Elements, Inc. $2,778 8 payments
  3. Flexion Therapeutics, Inc. $125 6 payments
  4. DePuy Synthes Sales Inc. $56 2 payments
  5. Painteq LLC $51 1 payment
  6. Ferring Pharmaceuticals Inc. $22 1 payment
  7. Misonix Inc $21 1 payment
  8. Boston Scientific Corporation $18 1 payment
  9. Sanofi-Aventis U.S. LLC $16 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Royalty or License $15,029 20 payments
  2. Food and Beverage $309 13 payments
Products named General payments · program years 2019–2024
  1. Medical Device $12,251 12 payments
  2. Cervical Plate -OTCC $2,025 4 payments
  3. TCS - Cervical Screws $379 2 payments
  4. Cervical Plate- OTCC $374 2 payments
  5. Zilretta $125 6 payments
  6. PAINTEQ $51 1 payment
  7. VIPER $36 1 payment
  8. EUFLEXXA $22 1 payment
  9. BoneScalpel $21 1 payment
  10. MONOVISC $19 1 payment
  11. Other $54 3 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

205

Median for Orthopedic Surgery: 203

Drug cost

$1,762

Median for Orthopedic Surgery: $1,433

Branded share of claims

19.5%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Etodolac Generic 22 $498
Methocarbamol Generic 45 $427
Methylprednisolone Generic 76 $425
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 40 $312
Gabapentin Generic 11 $79
Tramadol Hcl Generic 11 $22

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 11 billing codes

Paid by Medicare

$34,753

Medicare's payments for the services billed

Medicare patients

151

Average age 74

Services billed

465

82 women, 69 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 73%
Arthritis 63%
Ischemic heart disease 28%
Diabetes 25%
Chronic kidney disease 24%
Depression 18%
Cancer 17%
COPD 14%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

33 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record